Fecal Microbiota Transplantation: An Interview With Alexander Khoruts

A new, highly active sector of therapeutics in the form of fecal microbiota transplantation (FMT) has emerged in the last several years based on novel paradigms in medicine that are challenging to the regulators such as the US Food and Drug Administration (FDA). Dr Alexander Khoruts, associate professor of medicine at the University of Minnesota, Minneapolis, one of the leading researchers on FMT, discusses his work, the current regula­ tory challenges, and related topics.